
Radotinib inhibits acute myeloid leukemia cell proliferation via induction of mitochondrial-dependent apoptosis and CDK inhibitors
Keywords: AML, acute myeloid leukemia; BMCs, bone marrow cells; CML, chronic myeloid leukemia; TKI, tyrosine kinase inhibitorRadotinib (PubChem CID: 16063245)Radotinib; Acute myeloid leukemia; AML cell death; G0/G1 phase cell cycle arrest; Mitochondrial-dependent a